Research area
ADHD medication trials
Your next step can be a simple one: CNS Medication Trials can help you find out whether an ADHD study may be a fit for you or for someone you care for. These studies evaluate investigational medications and non-medication approaches for attention and focus in adults.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
ADHD medication studies in numbers
- ADHD medication studies recruiting in the U.S.
- 17
- states with a study site
- 30
- studies that accept healthy volunteers
- 5
Source: ClinicalTrials.gov. Data processed .
Find ADHD medication studies by state
These states have the most studies recruiting right now.
Massachusetts
8 studies recruiting.
California
6 studies recruiting.
Ohio
6 studies recruiting.
South Carolina
6 studies recruiting.
Florida
5 studies recruiting.
Nevada
5 studies recruiting.
ADHD medication studies recruiting now
As of November 17, 2026, 17 ADHD medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a medication, as each study is coded in the registry. This is what they have in common.
What they test
- medications17
- other approaches1
A study can test more than one.
Main purpose
- treating a condition15
- how care is delivered1
- other purposes1
Phase
- Phase 11
- Phase 21
- Phase 33
- Phase 412
Who runs them
- university, hospital or other10
- industry5
- government2
Who they enroll
- adults (18 to 64)7
- older adults (65 and over)5
- children (under 18)11
5 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 17 studies.
Recently updated ADHD medication studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Anaheim, CA · Atlanta, GA · Austin, TX · and 28 more U.S. locations
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Recruiting in
- Anaheim, CA · Atlanta, GA · Austin, TX · and 27 more U.S. locations
- Registry record
- NCT07717892 · updated
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Recruiting in
- Austin, TX · Bellaire, TX · Boston, MA · and 13 more U.S. locations
- Registry record
- NCT07759154 · updated
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Alkermes, Inc.
- Recruiting in
- Austin, TX · Bellevue, WA · Chino, CA · and 20 more U.S. locations
- Registry record
- NCT07755410 · updated
AWARE: Management of ADHD in Autism Spectrum Disorder
- Phase 4
- Ages 4 to 17
- All sexes
- Sponsor
- Daniel Coury
- Recruiting in
- Boston, MA · Charlottesville, VA · Cincinnati, OH · and 8 more U.S. locations
- Registry record
- NCT05916339 · updated
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Phase 4
- From 48 months, up to 69 months
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Anaheim, CA · Atlanta, GA · Baltimore, MD · and 34 more U.S. locations
- Registry record
- NCT04781140 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in the United States on ClinicalTrials.gov.
What ADHD studies look at
Once you start looking at ADHD studies, you will see that each one is built to answer a single, specific question. That is why what you would be asked to do changes from one study to the next. Taken together, this research evaluates investigational medications and non-medication approaches for attention and focus in adults.
Whatever a study is testing is investigational. Researchers are still finding out how well it works and which risks come with it. Learning those things is the reason the study exists.
Who may be able to take part
Before you can join a CNS medication trial, its study team will look at whether you fit that trial's requirements, and no two trials set them the same way. Your age may matter. So may your health history, any medications you take now, and what effect the condition has on you. Certain trials also take people who do not have the condition at all.
Sorting out eligibility is not your job. That check belongs to the study team, and it happens when you come in for screening. See how eligibility and screening work.
What taking part usually involves
A first conversation
Your first conversation is with a coordinator. Before anything else takes place, they give you a general picture of the CNS medication trial and take whatever questions you bring.
Informed consent
Next, you receive the complete details of the ADHD medication trial as a written document from the study team, with the known risks spelled out. Then the choice sits with you. You can agree, or you can decline.
Screening
Then comes screening. Through questions about your health and a set of tests, it becomes clear whether this ADHD medication trial is a suitable fit for you. Being screened is not the same as taking part, and some people go no further.
Study visits
Should you decide to join, visits follow on a set schedule so the team can keep track of your health. Staying is always up to you. You may stop taking part whenever you choose.
Questions about ADHD medication studies
Do I need a diagnosis to join a study about ADHD?
You will find out from the study team what their particular study requires, because the answer varies. A confirmed diagnosis is asked for in some ADHD medication trials. In the rest, you are assessed during the screening stage instead.
Would I have to change the care I receive now?
The study doctor will go over your current care with you, because studies differ: in some it can carry on, and in others it cannot. Until that conversation, make no changes to your care by yourself. You are also welcome to raise it with your regular doctor ahead of making a decision.
Is there a cost to take part?
As a participant in a CNS medication trial, you are generally not charged for the visits, the tests, or the medication that belong to the study. You can read about costs in more detail.
Ask about ADHD medication studies
Tell us a little about yourself here at CNS Medication Trials, and the next step is a coordinator reaching out to you. You can ask without committing to anything at all.
Independent information
- Attention-Deficit/Hyperactivity Disorder (ADHD) — National Institute of Mental Health (NIH)
- Clinical Trials – Information for Participants — National Institute of Mental Health (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)